
IBM Enters Second Phase of NIH Contract for Development of Verifiable Health Status Reporting and Contact Tracing
FEB. 25, 2021 IBM (NYSE: IBM) today announced that it has been awarded the second phase of the Digital Health Solutions for COVID-19 contract by the National Institutes of Health (NIH) to continue its work to develop and implement digital health solutions that are designed to help address the COVID-19 pandemic in an effort to help reopen public places.









